Cartilage Regeneration Market

o Growth Factor Technology
o Chondrocyte Transplantation
Non-Cell Based Approaches
o Cell Free Composites
o Tissue Scaffolds
Y-o-Y Growth Analysis, By Type of Treatment
Market Attractiveness Analysis, By Type of Treatment
Market Share Analysis, By Type of Treatment
2. Based on Application
Introduction
o Hyaline Cartilage Regeneration
o Fibrocartilage Regeneration
o Y-o-Y Growth Analysis, By Application
o Market Attractiveness Analysis, By Application
o Market Share Analysis, By Application
The market has been geographically segmented into North America, Europe, Asia-Pacific,
Latin America and Middle-East & Africa. As of 2016, North America leads the market,
accounting for the major global market share and expanding with the highest CAGR. North
America’s lead is warranted by the presence of high number of registered patients and
increasing use of cartilage repair or regeneration to treat sports injuries and other accidents.
Europe comes in second in terms of market share owing to the rising awareness about
blood related disorders and the swift availability of treatment in terms of plasma
fractionation. However, Asia-Pacific is expected to catch up fast during the forecast period
majorly because of the presence of huge population base, once the costs of cartilage
regeneration come down with growth in R&D and technology.
The major players in the Cartilage Regeneration Market are Zimmer Biomet Holdings, Inc.
(U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.),
and Arthrex Inc. (U.S.).
TABLE OF CONTENTS
1.Introduction
1.1 Market Definition
1.2 Study Deliverables